An innovative hybrid bioreactor system converts CO2 into single-cell protein, enhancing microbial electrosynthesis and ...

(TSXV: HI; OTCQB: HDRSF) (“Highland” or the “Company”) is pleased to announce the awarding of the Front-End Engineering and Design (FEED) contracts for both ...

Stämm’s bubble-free continuous laminar flow bioreactor: the Bioprocessor. As healthcare faces an increasing demand for therapies, Stämm enables the commercialization of biosimilars and different ...

Stämm's bubble-free continuous laminar flow bioreactor: the Bioprocessor. As healthcare faces an increasing demand for therapies, Stämm enables the commercialization of biosimilars and different ...

Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm’s bubble-free continuous laminar flow ...

Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz A-8010, Austria ...

14, 2025 /PRNewswire/ -- Stämm unveiled breakthrough results of its continuous bioreactor for monoclonal ... The biomanufacturing process for cell and gene therapies also benefits thanks to ...

The biomanufacturing process for cell and ... biologics production. Their continuous, bubble-free manufacturing platform with a novel 3D printed bioreactor enhances yields, reduces costs, and ...